Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
| Status: | Completed |
|---|---|
| Conditions: | Depression, Schizophrenia, Psychiatric, Diabetes, Bipolar Disorder |
| Therapuetic Areas: | Endocrinology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/6/2017 |
| Start Date: | July 2011 |
| End Date: | July 2015 |
This project tests a model for improving illness self-management among persons who have both
serious mental illness and diabetes and will be performed within a primary care setting at a
safety net hospital system. The information gained from the randomized trial will be
supplemented with reports from participants about their experiences of trying to improve
illness self-management. Improvements in self-management should result in a reduction of
psychiatric symptoms and improvements in functioning and physical health.
serious mental illness and diabetes and will be performed within a primary care setting at a
safety net hospital system. The information gained from the randomized trial will be
supplemented with reports from participants about their experiences of trying to improve
illness self-management. Improvements in self-management should result in a reduction of
psychiatric symptoms and improvements in functioning and physical health.
This project will test a novel intervention, Targeted Training in Illness Management (TTIM),
intended to improve both serious mental illness (SMI) and diabetes mellitus (DM)
self-management in 100 individuals with SMI-DM vs. 100 individuals with SMI-DM receiving
treatment as usual (TAU). The intervention will be conducted in a safety-net health system
primary care setting and will be conducted as a randomized controlled trial (RCT). The
primary effects of TTIM will be assessed with respect to SMI symptoms, Functional Status/Role
Impairment, General Health Status, and DM outcomes. Secondary outcomes include adherence to
psychotropic and DM medication, and engagement in healthy behaviors.
This assessment will include quantitative assessment of facilitators/barriers targeted by the
proposed intervention as well as a supplemental qualitative assessment. The qualitative
assessments will include input from patients and interventionists. Specific aims for the
qualitative analysis are to validate findings from the RCT, expand understanding of "key
active ingredients" of TTIM, and provide information to inform future studies on individuals
with SMI and related medical conditions.
intended to improve both serious mental illness (SMI) and diabetes mellitus (DM)
self-management in 100 individuals with SMI-DM vs. 100 individuals with SMI-DM receiving
treatment as usual (TAU). The intervention will be conducted in a safety-net health system
primary care setting and will be conducted as a randomized controlled trial (RCT). The
primary effects of TTIM will be assessed with respect to SMI symptoms, Functional Status/Role
Impairment, General Health Status, and DM outcomes. Secondary outcomes include adherence to
psychotropic and DM medication, and engagement in healthy behaviors.
This assessment will include quantitative assessment of facilitators/barriers targeted by the
proposed intervention as well as a supplemental qualitative assessment. The qualitative
assessments will include input from patients and interventionists. Specific aims for the
qualitative analysis are to validate findings from the RCT, expand understanding of "key
active ingredients" of TTIM, and provide information to inform future studies on individuals
with SMI and related medical conditions.
Inclusion Criteria:
1. Have Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder or major
depression
2. Have DM based upon either previous diagnosis or laboratory values
3. Be ≥ 18 years of age
4. Be able to communicate in English
5. Be able to provide written, informed consent to participation.
Exclusion Criteria:
1. Actively suicidal/homicidal
2. Unable to be rated on study rating scales
3. Demented
4. Pregnant
5. Unable to provide informed consent.
We found this trial at
1
site
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
Click here to add this to my saved trials
